ITMCTR2200005768
Not yet recruiting
Phase 1
A randomized controlled clinical study on eye acupuncture and acupuncture exercise rehabilitation therapy for patients with coronary heart disease after PCI
Hospital of Chengdu University of Traditional Chinese Medicine0 sitesTBD
Conditions/A
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- /A
- Sponsor
- Hospital of Chengdu University of Traditional Chinese Medicine
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients who are diagnosed with coronary heart disease as stable angina pectoris, non\-ST segment elevation myocardial infarction (NSTEMI), ST segment elevation myocardial infarction (STEMI) and receive transradial PCI surgery;
- •2\. Low\-risk patients in rehabilitation risk stratification after PCI; (low\-risk stratification criteria: (1\) Exercise or recovery period symptoms: no angina symptoms or ECG ischemia changes during exercise or recovery period; (2\) Arrhythmias: complex arrhythmias without rest or exercise; (3\) Complications after revascularization: vascular recanalization after AMI thrombolysis or CABG without complications; (4\) Psychological disorders: no psychological disorders (depression, anxiety, etc.); (5\) Left ventricular ejection fraction \>\= 50%; (6\) Peak oxygen uptake \[ml (min kg)] \>\= 20; (7\) Peak oxygen uptake percentage predicted value (% pred) \>\= 80; (8\) AT \[ml/(min·kg)] \>\= 15; (9\) Cardiac troponin concentration: normal; (10\) PCI elective single\-vessel disease.
- •Intermediate risk stratification criteria: (1\) Exercise or recovery period symptoms: moderate exercise (5\.0\-6\.9 METs) or angina symptoms or myocardial ischemia changes during recovery period; (2\) Arrhythmia: no complex ventricular arrhythmia at rest or during exercise; (3\) Post\-revascularization complications: no cardiogenic shock or heart failure after AMI, PCI or CABG; (4\) Psychological disorders: no serious psychological disorders (depression, anxiety, etc.); (5\) left ventricular ejection fraction 40% to 49%; (6\) peak oxygen uptake \[ml (min kg)] 15 to 19; (7\) Peak oxygen uptake percentage predicted value (% pred) 65\-79; (8\) AT \[ml/(min·kg)] 12\-14; (9\) Cardiac troponin concentration: normal; (10\) Emergency PCI, partial reconstruction PCI, multivessel disease. )
- •3\. Aged 45\-80 years;
- •4\. Patients with stable vital signs after 24 hours of pci operation;
- •5\. The patient signed the informed consent.
Exclusion Criteria
- •1\. Patients with severe complications such as malignant tumor, heart failure, respiratory failure, shock;
- •2\. Those with cognitive impairment, those with severe hearing and visual impairment affecting normal communication;
- •3\. There are severe liver and kidney function, immune dysfunction, etc.;
- •4\. Pregnant or lactating patients;
- •5\. There are contraindications to acupuncture.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Visual scanning training for loss of vision in half the visual field (hemianopia) - SEARCH trialISRCTN93008420niversity of Liverpool160
Active, not recruiting
Not Applicable
Assessing corneal integrity in healthy eyes and eyes after laser refractive surgeryPost-LASIKCorneal nerve functionEye - Diseases / disorders of the eyeEye - Normal eye development and functionACTRN12623000830695The University of Melbourne29
Completed
Not Applicable
Retinal Artery Study in participants with obstructive sleep apnoea treated with continuous positive airway pressureEndothelial functionSleep ApnoeaCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemRespiratory - Sleep apnoeaACTRN12610000311055Austin Health Department of Cardiology and Institute for Breathing and Sleep30
Not yet recruiting
Phase 2
Effects of Erand mul arka eye drop on simple allergic conjunctivitis.Health Condition 1: H103- Unspecified acute conjunctivitisCTRI/2022/05/042345Vivek P Harne
Not yet recruiting
Not Applicable
a clinical case controled trial for the intraocular tamponade in the vitrectomy for rhegmatogenous retinal detachment(RRD).Rhegmatogenous retinal detachmentJPRN-UMIN000006993Department of ophthalmology,Kansai medical university50